TABLE 5.

Numbers of clinically significant isolates detected, analyzed by bottle type and instrument detection for volume-compliant and noncompliant groups^a

Bottle type	No. of bottles with indicated volume compliance and assay status
	Compliant				Noncompliant, ≤10-ml vol				Noncompliant, >10-ml vol
	Significant positives	Both Virtuo and BTA3D	Virtuo only	BTA3D only	Significant positives	Both Virtuo and BTA3D	Virtuo only	BTA3D only	Significant positives	Both Virtuo and BTA3D	Virtuo only	BTA3D only
SA	45	34	6	5	12	7	1	4	13	7	4	2
SN	39	23	9	7	7	5	2	0	7	1	5	1
FA Plus	78	52	12	14	23	12	7	4	32	21	6	5
FN Plus	55	40	7	8	23	15	4	4	27	19	4	4
All	217	149	34	34	65	39	14	12	79	48	19	12

^aA total of 217 clinically significant positive isolates were recovered from 203 clinically significant bottle sets. No statistical difference was found in rates of detection between volume-compliant bottles and either type of non-volume-compliant bottle (P = 0.194 and P = 0.202, respectively).